Abstract Library

#3313 Carcinoid heart surgery: Review of outcomes from a single large centre

Introduction: Up to half of patients with carcinoid syndrome develop carcinoid heart disease and valve degeneration can lead to right heart failure. Surgical replacement of affected valves is an effective therapy. Peptide receptor radio-targeted therapy (PRRT) has demonstrated better progression-free survival compared to high dose sandostatin LAR.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Maclean R

Authors: Maclean R, Cope J, Hota S, Mulholland N, Ramage J,

Keywords: PRRT, Lutetium, Lutathera, carcinoid syndrome, valve replacement,

#1818 Patient Outcomes after Cardiac Surgery for Carcinoid Heart Disease Are Dependant Upon Successful Cytoreductive Multimodal Treatment and Control of Metastatic Neuroendocrine Disease

Introduction: Carcinoid Heart Disease (CHD) as a result of long standing carcinoid syndrome is associated with a poor prognosis due to development of valvular incompetence & right heart failure. Cardiac valve surgery is the main therapeutic option.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Jaber B, Ramsey E, Cowburn P, Tsang G, Armstrong T,

Keywords: Carcinoid heart disease, surgery,

#1138 Staged Percutaneous Treatment of Severe Carcinoid Heart Disease by Transfemoral Pulmonary Valve Replacement and Novel Vena Cava Valve Implantation

Introduction: Carcinoid heart disease with severe valve destruction represents the major cause of high morbidity and mortality in patients with carcinoid syndrome.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Stangl K

Authors: Pschowski R, Laule M, Baur A, Pape U, Pavel M,

Keywords: Carcinoid heart disease, percutaneous ,

#1041 Surgical Management of Carcinoid Valve Disease-Mechanical versus Tissue Valves

Introduction: The prosthetic valve of choice in patients with carcinoid valve disease (CVD) remains controversial due to the limited life expectancy of patients with advanced-stage neuroendocrine tumors (NETs) on one hand, and concerns regarding structural valve deterioration (SVD) on the other.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Glasberg S

Authors: Glasberg S, Atlan J, Korach A, Dabah A, Atlan K,

Keywords: carcinoid valve disease,

#261 Recognizing Carcinoid Heart Disease and Timing of Cardiac and Abdominal Procedures

Introduction: Recognition of right heart failure in Carcinoid Heart Disease enables a decision to be made concerning the proper timing of Cardiac and abdominal tumor-reductive surgery.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Zacks J, Shafir M, Castillo J, Choi J, Warner R,

Keywords: carcinoid heart disease, valve surgery, right heart failure, abdominal carcinoid, neuroendocrine ,